Francesco mocci affronta su Diritto Bancario il tema dell’accessibilità, ossia i…
ADVANT Altana advised the management of Kurma Partners on the acquisition of its entire share capital by Eurazeo.
Eurazeo, a long-standing investor and already a majority shareholder with a 70.6% stake since 2021, has announced the acquisition of the remaining shares in Kurma Partners, a leading French management company specialising in biotechnology and medical innovation. This transaction is in line with the agreements reached when the initial stake was acquired.
With nearly €600 million in assets under management, Kurma Partners has been a key player in European healthcare since 2009, supporting the most promising companies in the sector.
ADVANT Altana advised the management of Kurma Partners with a team including Géraldine Malfait and Jean-Nicolas Soret, partners, and Margaux Ripert, associate.
